| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 3 |
| 1 | AMLODIPINE | 2 |
| 2 | ASPIRIN | 2 |
| 3 | ASPIRIN 325 MG | 2 |
| 4 | ASPIRIN 81 MG | 2 |
| 5 | BISOPROLOL FUMARATE | 2 |
| 6 | CALCIUM | 2 |
| 7 | ECULIZUMAB | 2 |
| 8 | LAMIVUDINE | 2 |
| 9 | LAMIVUDINE ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYALURONIC ACID | 1 | 0.0009 |
| 1 | NIRSEVIMAB | 1 | 0.0006 |
| 2 | PENICILLIN G | 1 | 0.0004 |
| 3 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 1 | 0.0001 |
| 4 | LAMIVUDINE | 2 | 0.0001 |
| 5 | SUMATRIPTAN SUCCINATE | 2 | 0.0001 |
| 6 | SUMATRIPTAN | 2 | 0.0001 |
| 7 | HUMAN IMMUNOGLOBULIN G | 1 | 0.0000 |
| 8 | MAGNESIUM OXIDE | 2 | 0.0000 |
| 9 | LOPERAMIDE HYDROCHLORIDE | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 2 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Calcium [EPC] | 2 | 0.0000 |